Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
43.43
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi - American Depositary Shares
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
42
43
Next >
3 Dividend Stocks That Could Soar 51% to 58%, According to Wall Street
↗
October 24, 2022
Two of these three pay especially attractive dividends.
Via
The Motley Fool
US Stock Futures Lower Following Friday's Rally; Tesla In Focus
↗
October 24, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording sharp gains in the previous session. The Dow Jones jumped by around 750 points on Friday. All the...
Via
Benzinga
New Drugs Approvals Bring No Relief for Ailing Innovent Bio
↗
October 18, 2022
Key Takeaways: Innovent Bio has brought several drugs to market in recent years, including two announced last week, but is still losing money with no profits in sight The company has overhauled its...
Via
Benzinga
2 High-Yielding Dividend Stocks That Haven't Been This Cheap in Years
↗
October 14, 2022
Is now the time to buy Sanofi and Intel?
Via
The Motley Fool
3 Red-Hot Stocks That Could Continue to Beat the Market
↗
October 13, 2022
Investors are betting on these companies' revenue growth prospects.
Via
The Motley Fool
Sanofi In-Licenses Preclinical Genetic Disease Candidate From An Unknown Biotech
↗
October 04, 2022
Via
Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
↗
September 01, 2022
Via
Benzinga
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
↗
August 30, 2022
Via
Benzinga
Sanofi - Regeneron Tout Additional Positive Data From Flagship Dupixent Product
↗
October 11, 2022
Via
Benzinga
2 Top Healthcare Stocks to Buy Right Now
↗
October 08, 2022
Healthcare is about as sticky of a business model as you'll find.
Via
The Motley Fool
7 Under-$50 Stocks to Buy to Tap Into a Hidden Bull Market
↗
October 07, 2022
Those seeking compelling market ideas during this storm may want to consider these relevant under-$50 stocks to buy.
Via
InvestorPlace
2 Stocks Jumping in Thursday's Premarket Trading
↗
October 06, 2022
Get an early start on the events of the day.
Via
The Motley Fool
Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate
↗
October 06, 2022
Via
Benzinga
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
↗
September 29, 2022
Via
Benzinga
TG Therapeutics Touts Encouraging Data From Multiple Sclerosis Candidate
↗
August 25, 2022
Via
Benzinga
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
↗
September 23, 2022
Though successful in early testing, it wasn't enough to win a Phase 3 study.
Via
Investor's Business Daily
NASDAQ:SNY Investor Alert: Investigation over Potential Wrongdoing at Sanofi
↗
September 20, 2022
San Diego, CA -- (SBWIRE) -- 09/20/2022 -- An investigation on behalf of investors in shares of Sanofi (NASDAQ:SNY) was announced over potential breaches of fiduciary duties by certain directors at...
Via
SBWire
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
↗
September 20, 2022
Via
Benzinga
Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger
↗
September 19, 2022
Via
Benzinga
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
↗
September 16, 2022
Via
Benzinga
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
↗
September 14, 2022
Via
Benzinga
Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
↗
September 08, 2022
Via
Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
↗
September 06, 2022
Via
Benzinga
Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
↗
September 06, 2022
Via
Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
↗
September 01, 2022
Wall Street Journal
Via
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
↗
August 31, 2022
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.
Via
Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
↗
August 30, 2022
Via
Benzinga
Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources
↗
August 24, 2022
DarioHealth Corp. (NASDAQ: DRIO) recently announced
Via
Benzinga
MarketBeat: Week in Review 8/15 - 8/19
August 20, 2022
The economic reports continue to signal volatility. You can count on MarketBeat analysts to bring you the stocks and stories that are driving the market.
Via
MarketBeat
Topics
Economy
Workforce
Stocks That Hit 52-Week Lows On Thursday
↗
August 25, 2022
On Thursday, 63 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
42
43
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
